A phase II, double-blind, randomized, placebo-controlled non-inferiority trial of EpiCept NP-1 topical cream (2% ketamine / 4% amitriptyline) vs. oral gabapentin in postherpetic neuralgia

Trial Profile

A phase II, double-blind, randomized, placebo-controlled non-inferiority trial of EpiCept NP-1 topical cream (2% ketamine / 4% amitriptyline) vs. oral gabapentin in postherpetic neuralgia

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Jul 2011

At a glance

  • Drugs Amitriptyline/ketamine; Gabapentin
  • Indications Neuropathic pain; Postherpetic neuralgia
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 15 Sep 2009 Actual end date (1 Jun 2009) added as reported by ClinicalTrials.gov
    • 15 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 27 Jan 2009 Results are reported in a EpiCept Corporation media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top